JENNIFER EVANS: Open Payments
NPI 1841876158 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,707 in 95 payments from 17 companies in 2025. Trend: 2023 $1,825 · 2024 $3,109 · 2025 $3,707
Food & beverage: $2,547Consulting: $1,050Education: $110
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 19 | $1,522 |
| Janssen Biotech, Inc. | 9 | $370 |
| GENZYME CORPORATION | 4 | $333 |
| UCB, Inc. | 7 | $206 |
| Regeneron Healthcare Solutions, Inc. | 6 | $201 |
| ABBVIE INC. | 11 | $179 |
| LEO Pharma Inc. | 3 | $165 |
| Amgen Inc. | 9 | $158 |
| PFIZER INC. | 6 | $120 |
| Lilly USA, LLC | 4 | $107 |
Products named: Zoryve, DUPIXENT, TREMFYA, Bimzelx, ADBRY, Otezla, SKYRIZI, CIBINQO.
Industry payments across NV — which companies pay providers there.
